Pivotal role of cerebral interleukin-17-producing T cells in the delayed phase of ischemic brain injury

Takashi Shichita, Yuki Sugiyama, Hiroaki Ooboshi, Hiroshi Sugimori, Ryusuke Nakagawa, Ichiro Takada, Toru Iwaki, Yasunori Okada, Mitsuo Iida, Daniel J. Cua, Yoichiro Iwakura, Akihiko Yoshimura

研究成果: Article

475 引用 (Scopus)

抄録

Lymphocyte recruitment and activation have been implicated in the progression of cerebral ischemia-reperfusion (I/R) injury, but the roles of specific lymphocyte subpopulations and cytokines during stroke remain to be clarified. Here we demonstrate that the infiltration of T cells into the brain, as well as the cytokines interleukin-23 (IL-23) and IL-17, have pivotal roles in the evolution of brain infarction and accompanying neurological deficits. Blockade of T cell infiltration into the brain by the immunosuppressant FTY720 reduced I/R-induced brain damage. The expression of IL-23, which was derived mostly from infiltrated macrophages, increased on day 1 after I/R, whereas IL-17 levels were elevated after day 3, and this induction of IL-17 was dependent on IL-23. These data, together with analysis of mice genetically disrupted for IL-17 and IL-23, suggest that IL-23 functions in the immediate stage of I/R brain injury, whereas IL-17 has an important role in the delayed phase of I/R injury during which apoptotic neuronal death occurs in the penumbra. Intracellular cytokine staining revealed that T lymphocytes, but not CD4 + helper T cells, were a major source of IL-17. Moreover, depletion of T lymphocytes ameliorated the I/R injury. We propose that T lymphocytes, including T lymphocytes, could be a therapeutic target for mitigating the inflammatory events that amplify the initial damage in cerebral ischemia.

元の言語English
ページ(範囲)946-950
ページ数5
ジャーナルNature Medicine
15
発行部数8
DOI
出版物ステータスPublished - 2009 8

Fingerprint

T-cells
Interleukin-17
Interleukin-23
Brain Injuries
Brain
Reperfusion Injury
T-Lymphocytes
Cytokines
Brain Ischemia
Lymphocytes
Reperfusion
Infiltration
Ischemia
Brain Infarction
Lymphocyte Subsets
Immunosuppressive Agents
Lymphocyte Activation
Helper-Inducer T-Lymphocytes
Macrophages
Stroke

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

これを引用

Pivotal role of cerebral interleukin-17-producing T cells in the delayed phase of ischemic brain injury. / Shichita, Takashi; Sugiyama, Yuki; Ooboshi, Hiroaki; Sugimori, Hiroshi; Nakagawa, Ryusuke; Takada, Ichiro; Iwaki, Toru; Okada, Yasunori; Iida, Mitsuo; Cua, Daniel J.; Iwakura, Yoichiro; Yoshimura, Akihiko.

:: Nature Medicine, 巻 15, 番号 8, 08.2009, p. 946-950.

研究成果: Article

Shichita, T, Sugiyama, Y, Ooboshi, H, Sugimori, H, Nakagawa, R, Takada, I, Iwaki, T, Okada, Y, Iida, M, Cua, DJ, Iwakura, Y & Yoshimura, A 2009, 'Pivotal role of cerebral interleukin-17-producing T cells in the delayed phase of ischemic brain injury', Nature Medicine, 巻. 15, 番号 8, pp. 946-950. https://doi.org/10.1038/nm.1999
Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I その他. Pivotal role of cerebral interleukin-17-producing T cells in the delayed phase of ischemic brain injury. Nature Medicine. 2009 8;15(8):946-950. https://doi.org/10.1038/nm.1999
Shichita, Takashi ; Sugiyama, Yuki ; Ooboshi, Hiroaki ; Sugimori, Hiroshi ; Nakagawa, Ryusuke ; Takada, Ichiro ; Iwaki, Toru ; Okada, Yasunori ; Iida, Mitsuo ; Cua, Daniel J. ; Iwakura, Yoichiro ; Yoshimura, Akihiko. / Pivotal role of cerebral interleukin-17-producing T cells in the delayed phase of ischemic brain injury. :: Nature Medicine. 2009 ; 巻 15, 番号 8. pp. 946-950.
@article{6fa26250c2b44d8480a68f3f05d94770,
title = "Pivotal role of cerebral interleukin-17-producing T cells in the delayed phase of ischemic brain injury",
abstract = "Lymphocyte recruitment and activation have been implicated in the progression of cerebral ischemia-reperfusion (I/R) injury, but the roles of specific lymphocyte subpopulations and cytokines during stroke remain to be clarified. Here we demonstrate that the infiltration of T cells into the brain, as well as the cytokines interleukin-23 (IL-23) and IL-17, have pivotal roles in the evolution of brain infarction and accompanying neurological deficits. Blockade of T cell infiltration into the brain by the immunosuppressant FTY720 reduced I/R-induced brain damage. The expression of IL-23, which was derived mostly from infiltrated macrophages, increased on day 1 after I/R, whereas IL-17 levels were elevated after day 3, and this induction of IL-17 was dependent on IL-23. These data, together with analysis of mice genetically disrupted for IL-17 and IL-23, suggest that IL-23 functions in the immediate stage of I/R brain injury, whereas IL-17 has an important role in the delayed phase of I/R injury during which apoptotic neuronal death occurs in the penumbra. Intracellular cytokine staining revealed that T lymphocytes, but not CD4 + helper T cells, were a major source of IL-17. Moreover, depletion of T lymphocytes ameliorated the I/R injury. We propose that T lymphocytes, including T lymphocytes, could be a therapeutic target for mitigating the inflammatory events that amplify the initial damage in cerebral ischemia.",
author = "Takashi Shichita and Yuki Sugiyama and Hiroaki Ooboshi and Hiroshi Sugimori and Ryusuke Nakagawa and Ichiro Takada and Toru Iwaki and Yasunori Okada and Mitsuo Iida and Cua, {Daniel J.} and Yoichiro Iwakura and Akihiko Yoshimura",
year = "2009",
month = "8",
doi = "10.1038/nm.1999",
language = "English",
volume = "15",
pages = "946--950",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Pivotal role of cerebral interleukin-17-producing T cells in the delayed phase of ischemic brain injury

AU - Shichita, Takashi

AU - Sugiyama, Yuki

AU - Ooboshi, Hiroaki

AU - Sugimori, Hiroshi

AU - Nakagawa, Ryusuke

AU - Takada, Ichiro

AU - Iwaki, Toru

AU - Okada, Yasunori

AU - Iida, Mitsuo

AU - Cua, Daniel J.

AU - Iwakura, Yoichiro

AU - Yoshimura, Akihiko

PY - 2009/8

Y1 - 2009/8

N2 - Lymphocyte recruitment and activation have been implicated in the progression of cerebral ischemia-reperfusion (I/R) injury, but the roles of specific lymphocyte subpopulations and cytokines during stroke remain to be clarified. Here we demonstrate that the infiltration of T cells into the brain, as well as the cytokines interleukin-23 (IL-23) and IL-17, have pivotal roles in the evolution of brain infarction and accompanying neurological deficits. Blockade of T cell infiltration into the brain by the immunosuppressant FTY720 reduced I/R-induced brain damage. The expression of IL-23, which was derived mostly from infiltrated macrophages, increased on day 1 after I/R, whereas IL-17 levels were elevated after day 3, and this induction of IL-17 was dependent on IL-23. These data, together with analysis of mice genetically disrupted for IL-17 and IL-23, suggest that IL-23 functions in the immediate stage of I/R brain injury, whereas IL-17 has an important role in the delayed phase of I/R injury during which apoptotic neuronal death occurs in the penumbra. Intracellular cytokine staining revealed that T lymphocytes, but not CD4 + helper T cells, were a major source of IL-17. Moreover, depletion of T lymphocytes ameliorated the I/R injury. We propose that T lymphocytes, including T lymphocytes, could be a therapeutic target for mitigating the inflammatory events that amplify the initial damage in cerebral ischemia.

AB - Lymphocyte recruitment and activation have been implicated in the progression of cerebral ischemia-reperfusion (I/R) injury, but the roles of specific lymphocyte subpopulations and cytokines during stroke remain to be clarified. Here we demonstrate that the infiltration of T cells into the brain, as well as the cytokines interleukin-23 (IL-23) and IL-17, have pivotal roles in the evolution of brain infarction and accompanying neurological deficits. Blockade of T cell infiltration into the brain by the immunosuppressant FTY720 reduced I/R-induced brain damage. The expression of IL-23, which was derived mostly from infiltrated macrophages, increased on day 1 after I/R, whereas IL-17 levels were elevated after day 3, and this induction of IL-17 was dependent on IL-23. These data, together with analysis of mice genetically disrupted for IL-17 and IL-23, suggest that IL-23 functions in the immediate stage of I/R brain injury, whereas IL-17 has an important role in the delayed phase of I/R injury during which apoptotic neuronal death occurs in the penumbra. Intracellular cytokine staining revealed that T lymphocytes, but not CD4 + helper T cells, were a major source of IL-17. Moreover, depletion of T lymphocytes ameliorated the I/R injury. We propose that T lymphocytes, including T lymphocytes, could be a therapeutic target for mitigating the inflammatory events that amplify the initial damage in cerebral ischemia.

UR - http://www.scopus.com/inward/record.url?scp=68349160698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68349160698&partnerID=8YFLogxK

U2 - 10.1038/nm.1999

DO - 10.1038/nm.1999

M3 - Article

C2 - 19648929

AN - SCOPUS:68349160698

VL - 15

SP - 946

EP - 950

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 8

ER -